产品介绍 FAQs 评论(0)
宿主来源
Rabbit抗原名称
ATRIP分子别名
ATR-interacting protein; ATM and Rad3-related-interacting protein; AGS1免疫原
Synthetic Peptide细胞定位
NucleusAccession
Q8WXE1克隆号
S-1275-48抗体类型
Recombinant mAb抗体同种型
IgG反应种属 ?
Hu阳性样本
PC-3, HeLa, MCF7, HepG2, LNCaP, OVCAR-3, HEK-293预测反应种属
(反应种属缩写表)Mk, Ms纯化方式
Protein A浓度
0.5 mg/ml标记
Unconjugated性状
Liquid缓冲体系
PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300
储存条件
12 months from date of receipt / reconstitution, -20 °C as supplied
应用
WB ,IP稀释度
应用 稀释度 推荐种属 WB 1:1000 Hu IP 1:50 Hu
ATRIP stands for ATR-interacting protein. It works together with ATR (ataxia-telangiectasia mutated and Rad3-related) as a crucial component in the cell cycle checkpoint signaling pathway. Both ATR and ATRIP localize to intranuclear foci following DNA damage or replication inhibition. They are essential for the viability of human somatic cells and are interdependent in the cell cycle checkpoint signaling pathways. Furthermore, ATRIP plays a significant role in the DNA damage response. Together with ATR, it phosphorylates and transmits damage signals to effectors, initiating the repair process.
免疫印迹
WB result of ATRIP Recombinant Rabbit mAb
Primary antibody: ATRIP Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: PC-3 whole cell lysate 20 µg
Lane 2: HeLa whole cell lysate 20 µg
Lane 3: MCF7 whole cell lysate 20 µg
Lane 4: HepG2 whole cell lysate 20 µg
Lane 5: LNCaP whole cell lysate 20 µg
Lane 6: OVCAR-3 whole cell lysate 20 µg
Lane 7: HEK-293 whole cell lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 86 kDa
Observed MW: 90 kDa
免疫沉淀
ATRIP Rabbit mAb at 1/50 dilution (1 µg) immunoprecipitating ATRIP in 0.4 mg HeLa whole cell lysate.
Western blot was performed on the immunoprecipitate using ATRIP Rabbit mAb at 1/1000 dilution.
Secondary antibody (HRP) for IP was used at 1/1000 dilution.
Lane 1: HeLa whole cell lysate 20 µg (Input)
Lane 2: ATRIP Rabbit mAb IP in HeLa whole cell lysate
Lane 3: Rabbit monoclonal IgG IP in HeLa whole cell lysate
Predicted MW: 86 kDa
Observed MW: 90 kDa
FAQs
我们一般不推荐客户回收利用抗体。 因为抗体使用之后缓冲体系已经发生改变,不同客户在回收抗体的保存条件上也会有差异,所以抗体回收使用效果无法保证。另外,我们对一批抗体回收验证测试,测试结果显示不同抗体可回收次数不同,一般效价越高的抗体,可重复使用的次数越多,客户可根据实验情况来确定

申请试用
评论(0)